The AJMC® Biosimilars compendium is a comprehensive resource for news and expert insights into these biological products, including clinical research, patent and legal news, and regulatory updates.

Latest News

FDA image
FDA Approves Sandoz’ High-Concentration Version of Adalimumab Biosimilar, Hyrimoz

March 24th 2023

Both the high-concentration and low-concentration versions of adalimumab-adaz (Hyrimoz) injection will launch in July, along with a wave of other biosimilars to Humira (reference adalimumab).

rendering of a biosimilar molecule
Biosimilars May Not Be Cheap, but Are "Helping to Make Cancer Therapies More Accessible," Expert Says

March 18th 2023

Neulasta Onpro: A Coup de Grâce?

March 13th 2023

Stethoscope on financial papers | photo credit: shahrilkhmd -
Employer Playbook Suggests Strategies for Biosimilar Adoption, Navigating Adalimumab Launches

March 9th 2023

Image representing biosimilars: hafakot -
New WHO Biosimilar Guidelines Aim to Streamline, Clarify Regulations

March 8th 2023

Video Series
Video Interviews
managed care cast banner
Managed Care Cast

More News

© 2023 MJH Life Sciences
All rights reserved.